IL93143A0 - Transdermal drug delivery composition - Google Patents
Transdermal drug delivery compositionInfo
- Publication number
- IL93143A0 IL93143A0 IL93143A IL9314390A IL93143A0 IL 93143 A0 IL93143 A0 IL 93143A0 IL 93143 A IL93143 A IL 93143A IL 9314390 A IL9314390 A IL 9314390A IL 93143 A0 IL93143 A0 IL 93143A0
- Authority
- IL
- Israel
- Prior art keywords
- drug delivery
- transdermal drug
- delivery composition
- composition
- transdermal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/553—Renin inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30131089A | 1989-01-24 | 1989-01-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL93143A0 true IL93143A0 (en) | 1990-11-05 |
Family
ID=23162825
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL93143A IL93143A0 (en) | 1989-01-24 | 1990-01-23 | Transdermal drug delivery composition |
Country Status (6)
Country | Link |
---|---|
KR (1) | KR910700066A (ko) |
AU (1) | AU5041190A (ko) |
GR (1) | GR900100044A (ko) |
IE (1) | IE900245L (ko) |
IL (1) | IL93143A0 (ko) |
WO (1) | WO1990008553A1 (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11684624B2 (en) | 2009-06-24 | 2023-06-27 | Strategic Science & Technologies, Llc | Treatment of erectile dysfunction and other indications |
CN101875608B (zh) * | 2010-05-31 | 2014-01-22 | 沈阳药科大学 | 一类香芹醇酯类衍生物及含有该衍生物的经皮吸收制剂 |
JP2014504592A (ja) | 2010-12-29 | 2014-02-24 | ストラテジック サイエンス アンド テクノロジーズ, エルエルシー | 勃起不全および他の適応症の処置 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7800762A (nl) * | 1978-01-20 | 1979-07-24 | Acf Chemiefarma Nv | Vloeibare, voor injectie geschikte farmaceu- tische samenstellingen. |
US4353896A (en) * | 1981-06-08 | 1982-10-12 | Levy Michael A | Penetrating topical medicament |
EP0127426A1 (en) * | 1983-05-23 | 1984-12-05 | Takeda Chemical Industries, Ltd. | Percutaneous pharmaceutical compositions for external use |
GR81250B (en) * | 1983-12-22 | 1985-11-19 | American Home Prod | Menthol enhancement of transdermal drug delivery |
JPS60149530A (ja) * | 1984-01-13 | 1985-08-07 | Takeda Chem Ind Ltd | 水性製剤 |
CA1248450A (en) * | 1984-04-05 | 1989-01-10 | Kazuo Kigasawa | Soft patch |
EP0289900A1 (en) * | 1987-04-30 | 1988-11-09 | Abbott Laboratories | Topical antibacterial compositions |
-
1990
- 1990-01-13 AU AU50411/90A patent/AU5041190A/en not_active Abandoned
- 1990-01-13 KR KR1019900702095A patent/KR910700066A/ko not_active Application Discontinuation
- 1990-01-13 WO PCT/US1990/000530 patent/WO1990008553A1/en unknown
- 1990-01-22 IE IE900245A patent/IE900245L/xx unknown
- 1990-01-23 IL IL93143A patent/IL93143A0/xx unknown
- 1990-01-24 GR GR900100044A patent/GR900100044A/el unknown
Also Published As
Publication number | Publication date |
---|---|
KR910700066A (ko) | 1991-03-13 |
GR900100044A (el) | 1991-06-07 |
WO1990008553A1 (en) | 1990-08-09 |
IE900245L (en) | 1990-07-24 |
AU5041190A (en) | 1990-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2243778B (en) | Adhesive drug delivery composition | |
GB2185187B (en) | Transdermal drug delivery device | |
EP0431080A4 (en) | Compositions and methods for drug delivery and chromatography | |
IL86076A (en) | Transdermal drug delivery device | |
EP0274431A3 (en) | Drug delivery compositions and methods | |
EP0491812A4 (en) | Drug delivery compositions | |
JPS6479146A (en) | Drug composition | |
GB8825892D0 (en) | Pharmaceutical composition | |
GB2232891B (en) | Pharmaceutical composition | |
IL93143A0 (en) | Transdermal drug delivery composition | |
ZA893422B (en) | Pharmaceutical composition | |
EP0443027A4 (en) | Drug composition | |
GB9016056D0 (en) | Transdermal medicine delivery devices | |
IE893139L (en) | Controlled drug delivery | |
ZA896624B (en) | Composition and methods for drug delivery and chromatography | |
IE843209L (en) | Transdermal drug delivery | |
IE892613L (en) | Transdermal therapeutic composition | |
OA09637A (en) | Compositions and methods for drug delivery and chromatography | |
IL82753A0 (en) | Transdermal drug delivery device | |
IL83469A0 (en) | Transdermal drug delivery device | |
GB8901235D0 (en) | Pharmaceutical composition | |
GB8921274D0 (en) | Pharmaceutical composition | |
GB8916657D0 (en) | Pharmaceutical composition | |
IE890696L (en) | Pharmaceutical composition | |
IE892553L (en) | Pharmaceutical composition |